TrialJournal of cancer research and clinical oncology2018

A pharmacokinetics and pharmacodynamics equivalence trial of the proposed pegfilgrastim biosimilar, MYL-1401H, versus reference pegfilgrastim.

Cornelius F Waller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.